What is MRNA's current stock price?

As of now, MRNA is trading at $23.72, with a daily change of +6.08%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

MRNA Stock Analysis & IQ Rating | Moderna

MRNA

Moderna

$23.72

+$1.36 | +6.08%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$48.92

MKT CAP

$9.27B

52W Low

$22.28

VOL

$10.96M

P/E Ratio

N/A

AVG VOL

$11.42M

RSI

43.68

TREND

Downtrend

MRNA Stock IQ

Login to see Moderna (MRNA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

MRNA Target Price

Login to display

Strengths

MRNA Rewards

Earnings are forecast to grow

MRNA Rewards

Upgraded on attractively valued

MRNA Rewards

Outperform the market

Chart

$25.35 (-6.43%)

$24.09 (-1.54%)

$30.49 (-22.20%)

$44.44 (-46.62%)

1year

6month

3month

1month

MRNA Risk Level

MRNA has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Low

LOW

HIGH

MRNA Analysts Opinion

MRNA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

MRNA Analysts Opinion

MRNA Analysts opinion is positive but there was a setback from the past 3 months

MRNA Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

55%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

67%

71%

MRNA Street Sentiment

MRNA Street Sentiment is bullish and have positive views on the near-term outlook

MRNA Performance Sentiment

Sentiments overview associated with MRNA events and the stock performance.

55%

39%

Positive

Negative

18 out of 33
events present

13 out of 33
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$24.77

Resistance
Price

$23.62

Current Price Range

$28.14

Show methods +

Linked to MRNA

IQ

Close Price

Change

NVAX

3.77

6.47

+3.94%

AMGN

4.03

337.46

+1.13%

VALN

1.95

8.69

+1.06%

MRNA Latest Analysis +

Moderna Trims Pipeline and Takes On $1.5 Billion Loan as Cash Worries Loom.

Thu Nov 20, 2025

$22.36 | -7.53%

Potential

Moderna projects 10% growth next year. lifts outlook for year-end liquidity.

Thu Nov 20, 2025

$22.36 | -7.53%

Potential

Moderna stock rises after outlining growth strategy targeting 10% revenue growth by 2026.

Thu Nov 20, 2025

$22.36 | -7.53%

Momentum

Potential

Moderna takes $1.5 billion loan expects 10% revenue growth next year.

Thu Nov 20, 2025

$22.36 | -7.53%

Potential

Tuesday Sector Leaders: Healthcare Energy. The best performing sector as of midday Tuesday is the Healthcare sector up 1.8%. Within the sector Viatris Inc (Symbol: VTRS) and Moderna Inc (Symbol: MRNA) are two large stocks leading the way showing a gain of 6.5% and 4.7% respectively. Among healthcare ETFs one ETF fo

Tue Nov 11, 2025

$26.41 | +6.66%

Potential

B of A Securities Maintains Moderna (MRNA) Underperform Recommendation. Fintel reports that on November 10 2025 B of A Securities maintained coverage of Moderna (NasdaqGS:MRNA) with a Underperform recommendation. Analyst Price Forecast Suggests 74.00% Upside

Tue Nov 11, 2025

$26.41 | +6.66%

Rating

Moderna Inc. (NASDAQ:MRNA) Q3 2025 Earnings Call Transcript. Moderna Inc. (NASDAQ:MRNA) Q3 2025 Earnings Call Transcript November 6 2025 Moderna Inc. beats earnings expectations. Reported EPS is $-0.51282 expectations were $-2.15. Operator: Good day and thank you for standing by. Welcome to the Moderna’.s Third Quarter 2025 Conference Call. [Operator Instructions] Please be advised today’.s conference is being recorded. I would now like [….]

Fri Nov 7, 2025

$24.54 | +0.86%

Earnings

Moderna lowers 2025 cash cost guidance by $900M while advancing late-stage pipeline.

Thu Nov 6, 2025

$24.33 | +3.27%

Potential

Moderna Q3 Earnings Beat Stock Up on Revised 25 Spending Plans. MRNA posts narrower-than-expected Q3 loss and lifts liquidity outlook for 2025 as cost cuts and revised spending plans boost investor sentiment

Thu Nov 6, 2025

$24.33 | +3.27%

Activity

Earnings

Momentum

Potential

Moderna Cuts Costs As Covid Vaccine Sales Decline. Shares Rise. Moderna stock surged Thursday after the Covid vaccine-maker significantly cut its third-quarter costs and still managed to easily beat sales expectations.The post Moderna Cuts Costs As Covid Vaccine Sales Decline. Shares Rise appeared first on Investor'.s Business Daily.

Thu Nov 6, 2025

$24.33 | +3.27%

Activity

Earnings

Momentum

FAQ About MRNA Stock Insights

What is MRNA current stock price?

What are MRNA stock strengths?

What is MRNA Risk Level?

What is MRNA market cap and volume?

What is MRNA current Stock IQ?

Should I buy MRNA stock right now?

Is MRNA a Strong Buy right now?

What does a 'Strong Buy' rating mean for MRNA?

What does a 'Strong Sell' rating mean for MRNA?

What factors influence MRNA's Stock IQ?

Explore our MRNA Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored MRNA Stock Strategies
Effective Risk Management

FIND US ON

Receive our MRNA Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

MRNA

Moderna

Current Price

$23.72

+$1.36 | +6.08%

52W High

$48.92

MKT CAP

$9.27B

52W Low

$22.28

VOL

$10.96M

P/E Ratio

N/A

AVG VOL

$11.42M

RSI

43.68

TREND

Downtrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

MRNA Rewards

Earnings are forecast to grow

MRNA Rewards

Upgraded on attractively valued

MRNA Rewards

Outperform the market

Linked to MRNA

Symbol

IQ

Close

Change

NVAX

3.77

6.47

+3.94%

AMGN

4.03

337.46

+1.13%

VALN

1.95

8.69

+1.06%

MRNA Stock IQ

Login to unlock Moderna (MRNA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$25.35 (-6.43%)

$24.09 (-1.54%)

$30.49 (-22.20%)

$44.44 (-46.62%)

1year

6month

3month

1month

MRNA Analysts Opinion

MRNA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

MRNA Analysts Opinion

MRNA Analysts opinion is positive but there was a setback from the past 3 months

MRNA Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

55%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

67%

71%

MRNA Street Sentiment

MRNA Street Sentiment is bullish and have positive views on the near-term outlook

MRNA Risk Level

MRNA has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Low

LOW

HIGH

MRNA Performance Sentiment

Sentiments overview associated with MRNA events and the stock performance.

55%

39%

Positive

Negative

18 out of 33
events present

13 out of 33
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$24.77

Resistance
Price

$23.62

Current Price Range

$28.14

Show methods +

MRNA Latest Analysis

Moderna Trims Pipeline and Takes On $1.5 Billion Loan as Cash Worries Loom.

Thu Nov 20, 2025

$22.36 | -7.53%

Potential

Moderna projects 10% growth next year. lifts outlook for year-end liquidity.

Thu Nov 20, 2025

$22.36 | -7.53%

Potential

Moderna stock rises after outlining growth strategy targeting 10% revenue growth by 2026.

Thu Nov 20, 2025

$22.36 | -7.53%

Momentum

Potential

Moderna takes $1.5 billion loan expects 10% revenue growth next year.

Thu Nov 20, 2025

$22.36 | -7.53%

Potential

Tuesday Sector Leaders: Healthcare Energy. The best performing sector as of midday Tuesday is the Healthcare sector up 1.8%. Within the sector Viatris Inc (Symbol: VTRS) and Moderna Inc (Symbol: MRNA) are two large stocks leading the way showing a gain of 6.5% and 4.7% respectively. Among healthcare ETFs one ETF fo

Tue Nov 11, 2025

$26.41 | +6.66%

Potential

B of A Securities Maintains Moderna (MRNA) Underperform Recommendation. Fintel reports that on November 10 2025 B of A Securities maintained coverage of Moderna (NasdaqGS:MRNA) with a Underperform recommendation. Analyst Price Forecast Suggests 74.00% Upside

Tue Nov 11, 2025

$26.41 | +6.66%

Rating

Moderna Inc. (NASDAQ:MRNA) Q3 2025 Earnings Call Transcript. Moderna Inc. (NASDAQ:MRNA) Q3 2025 Earnings Call Transcript November 6 2025 Moderna Inc. beats earnings expectations. Reported EPS is $-0.51282 expectations were $-2.15. Operator: Good day and thank you for standing by. Welcome to the Moderna’.s Third Quarter 2025 Conference Call. [Operator Instructions] Please be advised today’.s conference is being recorded. I would now like [….]

Fri Nov 7, 2025

$24.54 | +0.86%

Earnings

Moderna lowers 2025 cash cost guidance by $900M while advancing late-stage pipeline.

Thu Nov 6, 2025

$24.33 | +3.27%

Potential

Moderna Q3 Earnings Beat Stock Up on Revised 25 Spending Plans. MRNA posts narrower-than-expected Q3 loss and lifts liquidity outlook for 2025 as cost cuts and revised spending plans boost investor sentiment

Thu Nov 6, 2025

$24.33 | +3.27%

Activity

Earnings

Momentum

Potential

Moderna Cuts Costs As Covid Vaccine Sales Decline. Shares Rise. Moderna stock surged Thursday after the Covid vaccine-maker significantly cut its third-quarter costs and still managed to easily beat sales expectations.The post Moderna Cuts Costs As Covid Vaccine Sales Decline. Shares Rise appeared first on Investor'.s Business Daily.

Thu Nov 6, 2025

$24.33 | +3.27%

Activity

Earnings

Momentum

Discover MRNA Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of MRNA. We're here to help you make informed investment decisions today.

FIND US ON

Receive our MRNA Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

MRNA Stock trends

MRNA Stock performance

MRNA Stock analysis

MRNA investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing MRNA

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing MRNA

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

MRNA Stock Analysis & IQ Rating | Moderna

MRNA Stock IQ

MRNA Target Price

MRNA Risk Level

MRNA Analysts Opinion

MRNA Street Sentiment

MRNA Performance Sentiment

Technical Price Levels

Explore our MRNA Stock insights

Receive our MRNA Daily Alerts

MRNA Stock IQ

MRNA Street Sentiment

MRNA Risk Level

Technical Price Levels

Discover MRNA Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of MRNA. We're here to help you make informed investment decisions today.

Receive our MRNA Daily Alerts

MRNA Runner Alarm